RSV(B)-Pre-F0

RSV(B)-Pre-F0 제품 목록

  • 속성

    Antibody (3)

  • 제품 라이브러리

    온라인 (3)

  • Mouse (3)

  • 태그

    - (3)

  • 마커

    Unconjugated (3)

RSV(B)-Pre-F0분자 배경

Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
NG-641EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAPPhase 1 ClinicalAkamis Bio Ltd, University Of OxfordSquamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis
상세
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호